{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:24:14Z","timestamp":1777605854154,"version":"3.51.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T00:00:00Z","timestamp":1546041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA100264"],"award-info":[{"award-number":["R01 CA100264"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P50CA093459"],"award-info":[{"award-number":["2P50CA093459"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA133996"],"award-info":[{"award-number":["R01CA133996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Duke Cancer Institute as part of the P30 Cancer Center Support Grant","award":["NIH CA014236"],"award-info":[{"award-number":["NIH CA014236"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,29]]},"DOI":"10.1093\/carcin\/bgy188","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T15:12:04Z","timestamp":1545232324000},"page":"279-288","source":"Crossref","is-referenced-by-count":8,"title":["Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival"],"prefix":"10.1093","volume":"40","author":[{"given":"Xiaomeng","family":"Wang","sequence":"first","affiliation":[{"name":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China"},{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghui","family":"Xu","sequence":"additional","affiliation":[{"name":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China"},{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichun","family":"Xie","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"},{"name":"Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dakai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, NH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher I","family":"Amos","sequence":"additional","affiliation":[{"name":"Institute for Clinical and Translational Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenying","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey E","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA"},{"name":"Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis, IN, USA"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Nan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN, USA"},{"name":"Channing Division of Network Medicine, Department of Medicine, Brigham and Women\u2019s Hospital, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqiu","family":"Song","sequence":"additional","affiliation":[{"name":"Cancer Center, The First Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-4439","authenticated-orcid":false,"given":"Qingyi","family":"Wei","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA"},{"name":"Department of Medicine, Duke University School of Medicine, Durham, NC, USA"},{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"2019042909132782400_CIT0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"2019042909132782400_CIT0002","author":"American Cancer Society","year":"2018"},{"key":"2019042909132782400_CIT0003","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2007.11.028","article-title":"Calcium signaling","volume":"131","author":"Clapham","year":"2007","journal-title":"Cell"},{"key":"2019042909132782400_CIT0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ceca.2017.07.006","article-title":"Calcium signaling and cell cycle: progression or death","volume":"70","author":"Humeau","year":"2018","journal-title":"Cell Calcium"},{"key":"2019042909132782400_CIT0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/27094","article-title":"Calcium\u2013a life and death signal","volume":"395","author":"Berridge","year":"1998","journal-title":"Nature"},{"key":"2019042909132782400_CIT0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"2019042909132782400_CIT0007","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10555-016-9634-0","article-title":"Calcium role in human carcinogenesis: a comprehensive analysis and critical review of literature","volume":"35","author":"Kadio","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"2019042909132782400_CIT0008","doi-asserted-by":"crossref","first-page":"31666","DOI":"10.1074\/jbc.R112.343061","article-title":"Calcium channels and pumps in cancer: changes and consequences","volume":"287","author":"Monteith","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"Pt B","key":"2019042909132782400_CIT0009","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.bbamem.2014.08.016","article-title":"Altered calcium signaling in cancer cells","volume":"1848","author":"Stewart","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"key":"2019042909132782400_CIT0010","doi-asserted-by":"crossref","first-page":"20130097","DOI":"10.1098\/rstb.2013.0097","article-title":"Remodelling of Ca2+ transport in cancer: how it contributes to cancer hallmarks","volume":"369","author":"Prevarskaya","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"2019042909132782400_CIT0011","first-page":"3760","article-title":"Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins","volume":"61","author":"Tsavaler","year":"2001","journal-title":"Cancer Res."},{"key":"2019042909132782400_CIT0012","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00432-015-2112-1","article-title":"TRPM8: a potential target for cancer treatment","volume":"142","author":"Liu","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2019042909132782400_CIT0013","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3390\/cancers7040882","article-title":"Roles of TRPM8 ion channels in cancer: proliferation, survival, and invasion","volume":"7","author":"Yee","year":"2015","journal-title":"Cancers (Basel)."},{"key":"2019042909132782400_CIT0014","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/bjd.15121","article-title":"Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma","volume":"176","author":"Maiques","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"2019042909132782400_CIT0015","doi-asserted-by":"crossref","first-page":"e89292","DOI":"10.1371\/journal.pone.0089292","article-title":"Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration","volume":"9","author":"Umemura","year":"2014","journal-title":"PLoS One"},{"key":"2019042909132782400_CIT0016","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ng.3373","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma","volume":"47","author":"Law","year":"2015","journal-title":"Nat. Genet."},{"key":"2019042909132782400_CIT0017","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.29429","article-title":"Genetic variants in Hippo pathway genes YAP1, TEAD1 and TEAD4 are associated with melanoma-specific survival","volume":"137","author":"Yuan","year":"2015","journal-title":"Int. J. Cancer"},{"key":"2019042909132782400_CIT0018","doi-asserted-by":"crossref","first-page":"5012","DOI":"10.1093\/hmg\/ddr415","article-title":"Genome-wide association study identifies novel loci predisposing to cutaneous melanoma","volume":"20","author":"Amos","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"2019042909132782400_CIT0019","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/ng1007-1181","article-title":"The NCBI dbGaP database of genotypes and phenotypes","volume":"39","author":"Mailman","year":"2007","journal-title":"Nat. Genet."},{"issue":"Database issue","key":"2019042909132782400_CIT0020","doi-asserted-by":"crossref","first-page":"D975","DOI":"10.1093\/nar\/gkt1211","article-title":"NCBI\u2019s database of genotypes and phenotypes: dbGaP","volume":"42","author":"Tryka","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"2019042909132782400_CIT0021","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/gepi.20533","article-title":"MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes","volume":"34","author":"Li","year":"2010","journal-title":"Genet. Epidemiol."},{"key":"2019042909132782400_CIT0022","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.dnarep.2011.12.005","article-title":"Exonuclease 1 (EXO1) gene variation and melanoma risk","volume":"11","author":"Song","year":"2012","journal-title":"DNA Repair (Amst)."},{"key":"2019042909132782400_CIT0023","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature12531","article-title":"Transcriptome and genome sequencing uncovers functional variation in humans","volume":"501","author":"Lappalainen","year":"2013","journal-title":"Nature"},{"key":"2019042909132782400_CIT0024","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jnci\/djh075","article-title":"Assessing the probability that a positive report is false: an approach for molecular epidemiology studies","volume":"96","author":"Wacholder","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"2019042909132782400_CIT0025","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Network","year":"2015","journal-title":"Cell"},{"key":"2019042909132782400_CIT0026","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2374","article-title":"Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival","volume":"8","author":"Roderick","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"2019042909132782400_CIT0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2016.11.001","article-title":"Targeting calcium signaling in cancer therapy","volume":"7","author":"Cui","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"2019042909132782400_CIT0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1517\/14728222.2013.741594","article-title":"Targeting Ca\u00b2\u207a transport in cancer: close reality or long perspective","volume":"17","author":"Prevarskaya","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"2019042909132782400_CIT0029","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s000180050364","article-title":"Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)","volume":"55","author":"Kakkar","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"2019042909132782400_CIT0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0167-4781(00)00293-1","article-title":"Human Ca2+\/calmodulin-dependent phosphodiesterase PDE1A: novel splice variants, their specific expression, genomic organization, and chromosomal localization","volume":"1517","author":"Michibata","year":"2001","journal-title":"Biochim. Biophys. Acta."},{"key":"2019042909132782400_CIT0031","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.coph.2011.10.003","article-title":"Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatment","volume":"11","author":"Levy","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"2019042909132782400_CIT0032","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"2019042909132782400_CIT0033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0901-5027(05)80873-2","article-title":"Calmodulin-dependent phosphodiesterase (PDE) 1 in human oral melanoma cell lines","volume":"34","author":"Shimizu","year":"2005","journal-title":"Int. J. Oral Surg."},{"key":"2019042909132782400_CIT0034","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/13543780903485642","article-title":"Targeting cancer with phosphodiesterase inhibitors","volume":"19","author":"Savai","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2019042909132782400_CIT0035","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/mnfr.201100307","article-title":"Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1","volume":"55","author":"Abusnina","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"2019042909132782400_CIT0036","first-page":"2553","article-title":"Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation","volume":"39","author":"Wei","year":"2018","journal-title":"Oncol. Rep."},{"key":"2019042909132782400_CIT0037","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1152\/physrev.00035.2006","article-title":"Inositol trisphosphate receptor Ca2+ release channels","volume":"87","author":"Foskett","year":"2007","journal-title":"Physiol. Rev."},{"key":"2019042909132782400_CIT0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Med. Genomics"},{"key":"2019042909132782400_CIT0039","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.bbamcr.2014.03.007","article-title":"Inositol 1,4,5-trisphosphate receptor-isoform diversity in cell death and survival","volume":"1843","author":"Ivanova","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"2019042909132782400_CIT0040","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1080\/15548627.2015.1083666","article-title":"ITPRs\/inositol 1,4,5-trisphosphate receptors in autophagy: from enemy to ally","volume":"11","author":"Decuypere","year":"2015","journal-title":"Autophagy"},{"key":"2019042909132782400_CIT0041","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1158\/0008-5472.CAN-14-0303","article-title":"ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy","volume":"74","author":"Messai","year":"2014","journal-title":"Cancer Res."},{"key":"2019042909132782400_CIT0042","doi-asserted-by":"crossref","first-page":"13653","DOI":"10.1073\/pnas.1103360108","article-title":"Functional SNP in the microRNA-367 binding site in the 3\u2019UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2019042909132782400_CIT0043","first-page":"513","article-title":"Functional polymorphism in the MicroRNA-367 binding site as a prognostic factor for colonic cancer","volume":"33","author":"Chae","year":"2013","journal-title":"Anticancer Res."},{"key":"2019042909132782400_CIT0044","first-page":"2075","article-title":"A polymorphism at the microRNA binding site in the 3\u2019 untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma","volume":"8","author":"Peng","year":"2015","journal-title":"Onco. Targets. Ther."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/40\/2\/279\/28541509\/bgy188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T15:38:27Z","timestamp":1556552307000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/40\/2\/279\/5266793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,12,31]]},"published-print":{"date-parts":[[2019,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgy188","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,12,31]]}}}